An American Society of Radiation Oncology survey has shined a spotlight on the impact prior authorization has on providers and patients. Adjuvant cemiplimab prolonged DFS compared with placebo for ...
Hematology-Oncology Associates of CNY has appointed Jennifer Pichoske as chief executive officer, effective Feb. 15. She succeeds longtime CEO Maryann Roefaro, who is retiring from the position ...